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UrticariaDear Editor,Cryopyrin-associated periodic syndrome (CAPS) is a rare,
monogenic, autoinflammatory disorder with autosomal dom-
inant transmission. This syndrome encompasses a broad
spectrum of phenotypes, which increase in severity from
familial cold urticaria through Muckle–Wells syndrome and
CINCA/NOMID. All phenotypic variants are usually related to
mutations of the cryopyrin gene (NLRP3) [1,2]. A family
history of childhood-onset, inflammatory attacks involving
fever, urticarial skin rash, arthralgia and ocular, auditory and
neurological disorders are suggestive of CAPS [1,2].
A 19 year-old Caucasian woman presented at our outpa-
tient clinic for chronic urticaria that had started at the age of
9. She was a single child and had an otherwise unremarkable
personal and family medical history. From 2005 onwards, she
had suffered attacks of arthralgia of the knees, wrists and
ankles lasting a few days. Her immunological and allergological
test results were unremarkable, other than a serum C-reactive
protein level of 30 mg/L and neutrophilia (17 × 109/L) during
an attack. There was no proteinuria and a skin biopsy was
normal. The initial diagnosis was delayed pressure urticaria.
From 2009 onwards, extensive attacks of urticaria occurred
every 1 to 3 days. The patient never experienced fever, ocular
symptoms or hearing loss. Betamethasone and antihistamine
treatments were prescribed. The patient developed Cushing's
syndrome and severe depression.
Given the patient's history of childhood-onset urticaria
with arthralgia and an intermittent inflammatory syndrome,
CAPS was then suspected. DNA was extracted from periph-
eral blood leukocytes and the nine coding exons of NLRP3
and their flanking intronic sequences were PCR-amplified☆☆ Authorship: All authors had access to the data and played a role in writing this
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1521-6616 Crown Copyright © 2013 Published by Elsevier Inc.
http://dx.doi.org/10.1016/j.clim.2013.05.020
Open access and sequenced. The patient was found to be heterozygous
for a novel polymorphism (K375E (p.Lys375Glu; c.1123A N G))
in NLRP3 exon 3. Interestingly, her mother had the same
polymorphism but was asymptomatic. The patient's father did
not carry any mutations in NLRP3.
The serum amyloid protein (SAA) level was increased
(59 mg/L). Treatment with the interleukin 1 receptor antag-
onist anakinra was initiated and led to a marked decrease in
the extent and intensity of inflammatory symptoms. A switch
to canakinumab led to the total disappearance of symptoms
and normalization of the SAA level.
It is known that CAPS is caused by a heterozygous mutation
in NLRP3 [1,2]. Cryopyrin has a key role in the innate immune
system. In response to pathogens and stress signals, cryopyrin
triggers the formation of the inflammasome, a multiprotein
complex that amplifies the inflammatory response through
the IL-1β signaling pathway [1]. The various NLRP3 mutations
have distinct phenotypic expressions and suggest the existence
of a clinical continuum [1,3]. The K375E sequence variation
found in our patient has not previously been reported. The
pathogenicity of the K375E variant is supported by several lines
of evidence: (i) it is not present in databases of sequence
variations from the general population (NCBI, Ensembl, 1000
Genomes, Exome Variant Server, etc.); (ii) it affects the
nucleotide binding site domain of cryopyrin, which contains
nearly all the other NLRP3mutations described to date [3]; and
(iii) it affects an evolutionarily conserved residue. The
symptoms associated with high levels of SAA and the complete
resolution of the patient's clinical and biological manifestations
following anti-IL1 treatment are strongly supportive of a
diagnosis of CAPS.
The absence of symptoms in the patient's mother is consistent
with incomplete penetrance of the disease phenotype, which is
frequently observed in CAPS. One ormore cofactors are probably
involved in expression of the different disease phenotypes.
The atypical presentation in the present case (only urticarial
rash and arthralgia) delayed the diagnosis and led to severe
iatrogenic complications. A rigorous analysis of the biological
data should have prompted an earlier diagnosis, since there are
few causes of urticaria in an inflammatory context and the
immunological tests were negative.
This case report emphasizes the fact that rare genetic
diseases can still be diagnosed in adulthood but often
present in an incomplete or atypical manner.
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